FUNDE（香港）投资控股与Guanze Medical (2427)联合发布澄清公告进一步说明公众持股量及上市地位安排

公告速递

Feb 20

富德（香港）投资控股有限公司（FUNDE（香港）投资控股）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股份代号：2427）于2026年2月20日联合发布澄清公告，针对2026年2月11日刊发的规则3.5公告中“公众持股量及维持本公司的上市地位”章节进行了内容替换。公告再次强调，若要约届满时公众持股量不足，香港联合交易所有限公司可能会暂停该公司股份交易，并在无法于18个月内恢复充足公众持股量的情况下考虑取消上市。

上述公告指出，要约人及其一致行动人士若通过要约收购导致公共持股比例不足，将采取必要举措恢复公众持股量，包括但不限于向独立第三方或市场减持相关股份。同时，上市规则要求，如要约截止时未能满足25%的公众持股量要求，Guanze Medical可向联交所申请短期豁免，并需尽快采取措施提升公众持股比例。

公告还称，要约人拟在要约截止后继续维持Guanze Medical于联交所的上市地位，且将履行相关承诺，确保持股量符合上市规则第13.32B条之规定。除上述更新内容外，规则3.5公告的其他信息与条款保持不变。该澄清公告与此前的公告需一并参阅。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1108759880"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108759880\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108759880?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-02-20 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108759880","market":"hk","top_or_hot":-1,"title":"FUNDE（香港）投资控股与Guanze Medical (2427)联合发布澄清公告 进一步说明公众持股量及上市地位安排","media":"公告速递","content":"<p>富德（香港）投资控股有限公司（FUNDE（香港）投资控股）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股份代号：2427）于2026年2月20日联合发布澄清公告，针对2026年2月11日刊发的规则3.5公告中“公众持股量及维持本公司的上市地位”章节进行了内容替换。公告再次强调，若要约届满时公众持股量不足，香港联合交易所有限公司可能会暂停该公司股份交易，并在无法于18个月内恢复充足公众持股量的情况下考虑取消上市。</p>\n<p>上述公告指出，要约人及其一致行动人士若通过要约收购导致公共持股比例不足，将采取必要举措恢复公众持股量，包括但不限于向独立第三方或市场减持相关股份。同时，上市规则要求，如要约截止时未能满足25%的公众持股量要求，Guanze Medical可向联交所申请短期豁免，并需尽快采取措施提升公众持股比例。</p>\n<p>公告还称，要约人拟在要约截止后继续维持Guanze Medical于联交所的上市地位，且将履行相关承诺，确保持股量符合上市规则第13.32B条之规定。除上述更新内容外，规则3.5公告的其他信息与条款保持不变。该澄清公告与此前的公告需一并参阅。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FUNDE（香港）投资控股与Guanze Medical (2427)联合发布澄清公告 进一步说明公众持股量及上市地位安排</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFUNDE（香港）投资控股与Guanze Medical (2427)联合发布澄清公告 进一步说明公众持股量及上市地位安排\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1097772564\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">公告速递 </p>\n<p class=\"h-time\">2026-02-20 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>富德（香港）投资控股有限公司（FUNDE（香港）投资控股）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股份代号：2427）于2026年2月20日联合发布澄清公告，针对2026年2月11日刊发的规则3.5公告中“公众持股量及维持本公司的上市地位”章节进行了内容替换。公告再次强调，若要约届满时公众持股量不足，香港联合交易所有限公司可能会暂停该公司股份交易，并在无法于18个月内恢复充足公众持股量的情况下考虑取消上市。</p>\n<p>上述公告指出，要约人及其一致行动人士若通过要约收购导致公共持股比例不足，将采取必要举措恢复公众持股量，包括但不限于向独立第三方或市场减持相关股份。同时，上市规则要求，如要约截止时未能满足25%的公众持股量要求，Guanze Medical可向联交所申请短期豁免，并需尽快采取措施提升公众持股比例。</p>\n<p>公告还称，要约人拟在要约截止后继续维持Guanze Medical于联交所的上市地位，且将履行相关承诺，确保持股量符合上市规则第13.32B条之规定。除上述更新内容外，规则3.5公告的其他信息与条款保持不变。该澄清公告与此前的公告需一并参阅。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1108759880","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108759880","pubTimestamp":1771577617,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"富德（香港）投资控股有限公司与Guanze Medical Information Industry  Co., Ltd.于2026年2月20日联合发布澄清公告，针对2026年2月11日刊发的规则3.5公告中“公众持股量及维持本公司的上市地位”章节进行了内容替换。公告再次强调，若要约届满时公众持股量不足，香港联合交易所有限公司可能会暂停该公司股份交易，并在无法于18个月内恢复充足公众持股量的情况下考虑取消上市。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"FUNDE (HK) Investment Holdings and Guanze Medical (2427) jointly issued a clarification announcement to further explain the public float and listing status arrangement","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"富德（香港）投资控股有限公司（FUNDE（香港）投资控股）与Guanze Medical Information Industry (Holding) Co., Ltd.（Guanze Medical，股份代号：2427）于2026年2月20日联合发布澄清公告，针对2026年2月11日刊发的规则3.5公告中“公众持股量及维持本公司的上市地位”章节进行了内容替换。公告再次强调，若要约届满时公众持股量不足，香港联合交易所有限公司可能会暂停该公司股份交易，并在无法于18个月内恢复充足公众持股量的情况下考虑取消上市。\n上述公告指出，要约人及其一致行动人士若通过要约收购导致公共持股比例不足，将采取必要举措恢复公众持股量，包括但不限于向独立第三方或市场减持相关股份。同时，上市规则要求，如要约截止时未能满足25%的公众持股量要求，Guanze Medical可向联交所申请短期豁免，并需尽快采取措施提升公众持股比例。\n公告还称，要约人拟在要约截止后继续维持Guanze Medical于联交所的上市地位，且将履行相关承诺，确保持股量符合上市规则第13.32B条之规定。除上述更新内容外，规则3.5公告的其他信息与条款保持不变。该澄清公告与此前的公告需一并参阅。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}